Increased pancreatic fat fraction Is present in obese adolescents with metabolic syndrome

Journal of Pediatric Gastroenterology and Nutrition

Volumn 54, Issue 6, 2012, Pages 720-726

  Maggio, Albane B R ^a   Mueller, Pascal ^b   Wacker, Julie ^c   Viallon, Magalie ^c   Belli, Dominique C ^c   Beghetti, Maurice ^b   Farpour Lambert, Nathalie J ^a   McLin, Valérie A ^c  

^a Pediatric Sport Medicine and Obesity Care Program   (Switzerland)

^b Ostschweizer Kinderspital   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

children; Glucose metabolism; Obesity; Pancreatic steatosis

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE; BODY FAT; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; DIET RESTRICTION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FAT FRACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, HDL; FASTING; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LEPTIN; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; OBESITY; PANCREAS; TRIGLYCERIDES;

EID: 84861329365     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318244a685     Document Type: Article

References (41)

1. Zimmermann MB, Gubeli C, Puntener C, et al. Overweight and obesity in 6-12 year old children in Switzerland. Swiss Med Wkly 2004;134: 523-8. (Pubitemid 39389964)
2. Gutin B, Johnson MH, Humphries MC, et al. Relationship of visceral adiposity to cardiovascular disease risk factors in black and white teens. Obesity (Silver Spring) 2007;15:1029-35. (Pubitemid 46740979)
3. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in nonadipose tissue and lipotoxicity. Physiol Behav 2008;94:231-41. (Pubitemid 351615422)
4. Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford) 2007;9:312-8. (Pubitemid 47271323)
5. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A 1978; 86A:367-73. (Pubitemid 9031936)
6. Stamm BH. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum Pathol 1984;15:677-83. (Pubitemid 15161459)
7. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007;20:933-42. (Pubitemid 350074312)
8. Kovanlikaya A, Mittelman SD, Ward A, et al. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol 2005;35:601-7. (Pubitemid 40724032)
9. Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007;30:2916-21. (Pubitemid 350083144)
10. Carpentier AC, Bourbonnais A, Frisch F, et al. Plasma nonesterified fatty acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index. J Clin Endocrinol Metab 2010;95:1256-64.
11. Lingvay I, Esser V, Legendre JL, et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009;94:4070-6.
12. Manco M, Marcellini M, Devito R, et al. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008;32:381-7. (Pubitemid 351271778)
13. Schwenzer NF, Machann J, Martirosian P, et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 2008;43:330-7. (Pubitemid 351572210)
14. Fishbein MH, Gardner KG, Potter CJ, et al. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997;15:287-93. (Pubitemid 27280484)
15. Rolland-Cachera MF, Cole TJ, Sempe M, et al. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991;45: 13-21.
16. WHO Child Growth Standards: Length/Height-for-Age, Weight-for- Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for- Age: Methods and Development. Geneva: World Health Organization; 2006:312.
17. Allard P, Delvin EE, Paradis G, et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin Chem 2003;49:644-9. (Pubitemid 36379530)
18. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin lamp. Diabetes Care 1999;22:1462-70. (Pubitemid 29418240)
19. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(suppl 1):S43-8.
20. Phillips DI, Clark PM, Hales CN, et al. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994;11:286-92. (Pubitemid 24144145)
21. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-76.
22. Jolliffe CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J Am Coll Cardiol 2007;49: 891-8. (Pubitemid 46275357)
23. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153: 189-94. (Pubitemid 14043406)
24. Hines CD, Yu H, Shimakawa A, et al. T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom. J Magn Reson Imaging 2009;30: 1215-22.
25. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212:876-84. (Pubitemid 29410996)
26. Brambilla P, Bedogni G, Moreno LA, et al. Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children. Int J Obes (Lond) 2006;30:23-30. (Pubitemid 41790773)
27. D'Adamo E, Marcovecchio ML, Giannini C, et al. The possible role of liver steatosis in defining metabolic syndrome in prepubertal children. Metabolism 2010;59:671-6.
28. Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007; 357:1301-10. (Pubitemid 47481452)
29. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995;44:1249-58.
30. Lee Y, Lingvay I, Szczepaniak LS, et al. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond) 2010;34:396-400.
31. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7-18.
32. El-AssaadW, Buteau J, Peyot ML, et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 2003;144:4154-63.
33. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003;278:45777-84. (Pubitemid 37432722)
34. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 2003;100:7265-70. (Pubitemid 36706427)
35. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-8.
36. Mandrup-Poulsen T. Beta-cell apoptosis: stimuli and signaling. Diabetes 2001;50 (suppl 1):S58-63.
37. Bastard JP, Maachi M, Van Nhieu JT, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both invivo and in vitro. J Clin Endocrinol Metab 2002;87:2084-9. (Pubitemid 34521492)
38. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7. (Pubitemid 30430551)
39. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-30. (Pubitemid 38063705)
40. van Geenen EJ, Smits MM, Schreuder TC, et al. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 2010;39:1185-90.
41. Cali AM, De Oliveira AM, Kim H, et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 2009;49:1896-903.